Taxol (paclitaxel) plus recombinant human granulocyte colony-stimulating factor in the treatment of metastatic breast cancer.

Seidman, A D; Norton, L; Reichman, B S; Crown, J P; Yao, T J; Hakes, T B; Lebwohl, D E; Gilewski, T A; Hudis, C A; Surbone, A

Seidman, A D; Norton, L; Reichman, B S; Crown, J P; Yao, T J; Hakes, T B; Lebwohl, D E; Gilewski, T A; Hudis, C A; Surbone, A.

Affiliation

Seidman AD; Memorial Sloan-Kettering Cancer Center, New York, NY 10021.

Oncology ; 51 Suppl 1: 33-9, 1994 Oct.

Article in En | MEDLINE | ID: mdl-7526308

Subject(s)

Antineoplastic Combined Chemotherapy Protocols/therapeutic use; Breast Neoplasms/therapy; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols/adverse effects; Breast Neoplasms/pathology; Female; Granulocyte Colony-Stimulating Factor/administration & dosage; Granulocyte Colony-Stimulating Factor/adverse effects; Humans; Infusions, Intravenous; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Paclitaxel/administration & dosage; Paclitaxel/adverse effects; Remission Induction; Salvage Therapy

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Antineoplastic Combined Chemotherapy Protocols Limits: Adult / Aged / Female / Humans / Middle aged Language: En Journal: Oncology Year: 1994 Document type: Article Country of publication: Switzerland

Search on Google

Add to My VHL

XML

PubMed Links